ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Favrille


Include trials that are no longer recruiting patients.

2 studies were found.
1.RecruitingRituxan plus FavId (idiotype vaccine) for low-grade non-Hodgkin's lymphoma
Condition: Non-Hodgkin's Lymphoma
2.RecruitingVaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act